Alterity Therapeutics (ATHE) Assets (2009 - 2026)

Alterity Therapeutics has reported Assets for 18 years, with the latest figure at $32.6 million in Q2 2026.

• On a quarterly basis, Assets rose 10.74% year-over-year to $32.6 million in Q2 2026; TTM through Jun 2026 was $32.6 million, a 10.74% increase from a year earlier, with the FY2026 full-year figure at $32.6 million, up 10.74% from the prior year.
• Assets was $32.6 million for Q2 2026 at Alterity Therapeutics, down from $37.4 million in the prior quarter.
• The five-year high for Assets was $37.4 million in Q4 2025, with the low at $192237.4 in Q2 2024.
• Average Assets over 5 years is $19.2 million, with a median of $21.9 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Assets slumped 99.08% in 2023, then soared 15233.54% in 2025.
• Over 5 years, Assets stood at $21.9 million in 2022, then plunged by 34.13% to $14.4 million in 2023, then sank by 52.26% to $6.9 million in 2024, then soared by 441.83% to $37.4 million in 2025, then fell by 12.65% to $32.6 million in 2026.
• The last three Assets figures came in at $32.6 million (Q2 2026), $37.4 million (Q4 2025), and $29.5 million (Q2 2025), per Business Quant data.